BASF Opens New Hub for Biopharma, Pharma Ingredients in US

Published on 06/17/2025 at 23:55

MT Newswires

This article is reserved for members

Unlock the article: REGISTER NOW!

100% Free Registration

Already a customer? Log In

Latest news about BASF SE

Chemical Sector Proves Resilient - Oddo: Market Expectations Too Pessimistic	Jul. 03	DP
BASF: sells Styrodur business to BACHL	Jul. 02
BASF: acquires Alsachimie	Jul. 02
Chemical Industry in Germany Sees Surge in Optimism: "Lower Electricity Tax Provides a Boost"	Jul. 01	RE
Chemical Industry Sentiment Rises Sharply	Jul. 01	DP
BASF Announces Senior Leadership Changes for Its Global Electronic Materials Business Unit, Effective July 1, 2025	Jun. 30	CI
BASF SE completed the acquisition of the remaining 49% stake in Alsachimie S.A.S. from DOMO Chemicals GmbH.	Jun. 30	CI
DAX Opens Higher as Powell Succession Debate Takes Center Stage	Jun. 27	RE
BASF SE : Berenberg is Neutral	Jun. 27	ZD
BASF SE : Warburg Research gives a Neutral rating	Jun. 26	ZD
BASF SE : UBS is Neutral	Jun. 25	ZD
BASF SE : JP Morgan reiterates its Sell rating	Jun. 25	ZD
Relief for Farmers on Fertilizer Regulations	Jun. 24	DP
BASF SE : Buy rating from DZ Bank	Jun. 24	ZD
Mwb Research Cuts BASF Price Target, Financial Estimates Amid Rising Oil Prices	Jun. 24	MT
German Stocks Flash Red Amid Escalating Middle East Tensions	Jun. 23	MT
Baptista Research Kicks Off BASF Coverage at Outperform	Jun. 23	MT
BASF SE : Deutsche Bank keeps its Buy rating	Jun. 23	ZD
BASF SE : Goldman Sachs reaffirms its Buy rating	Jun. 20	ZD
BASF SE : Jefferies sticks Neutral	Jun. 20	ZD
BASF Opens New Hub for Biopharma, Pharma Ingredients in US	Jun. 17	MT
BASF SE : JP Morgan maintains a Sell rating	Jun. 16	ZD
German Stocks Deep in the Red as Middle East Tensions Flare	Jun. 13	MT
Berenberg Trims BASF Earnings Forecasts, Says Q2 Unlikely to 'Radically Change' Outlook	Jun. 13	MT
BASF SE : Berenberg sticks Neutral	Jun. 13	ZD